ACP
ZBH icon

Acuta Capital Partners’s Zimmer Biomet ZBH Stock Holding History

Acuta Capital Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,450
Closed -$1.55M – 76
2016
Q4 		$1.55M Buy
+15,450
New +$1.66M 0.58% 30

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acuta Capital Partners's ZBH Position: Q1 2017 in Review

Acuta Capital Partners sold out of Zimmer Biomet (ZBH) in Q1 2017, closing a stake of 15,450 shares — an estimated $1.55M sold.

Acuta Capital Partners first reported a position in ZBH in Q4 2016 and held it in 1 quarter. The position peaked at $1.55M in Q4 2016. 817 funds tracked by Wall St. Rank hold ZBH as of Q1 2017.

  • Acuta Capital Partners reported no remaining Zimmer Biomet position as of Q1 2017 after selling out during the quarter.
  • Acuta Capital Partners sold 15,450 Zimmer Biomet shares in Q1 2017, an estimated $1.55M.
  • Acuta Capital Partners first reported a position in Zimmer Biomet in Q4 2016 and held it in 1 quarter.
  • Acuta Capital Partners's Zimmer Biomet position peaked at $1.55M in Q4 2016.
  • 817 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2017.

Based on Acuta Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.